Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Indus Biosciences is a premier contract research organization (CRO) based in Hyderabad, India, that provides integrated drug discovery and development services. Since its acquisition by Jubilant Biosys in 2005, the company has functioned as a key component of Jubilant's global discovery chemistry operations. Indus Biosciences specializes in medicinal chemistry, custom synthesis, and lead optimization for small molecule drug candidates. The organization serves a diverse clientele, including global pharmaceutical giants and emerging biotech firms, by offering scalable R&D solutions. Its facilities in Hyderabad are equipped to handle complex chemical transformations and accelerate the transition from hit identification to clinical candidate selection.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Indus Biosciences.